Regeneron Pharmaceuticals Business Finance Contracts & Agreements

47 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amended and Restated Guaranty, dated as of March 27, 2023, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC,...
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2023
Third Amended and Restated Participation Agreement, dated as of March 27, 2023, by and among Old Saw Mill Holdings LLC, as lessee, Bank of America, N.A., as administrative agent,...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2023
Credit Agreement, dated as of December 19, 2022, by and among Regeneron Pharmaceuticals, Inc., as a borrower and guarantor; certain direct subsidiaries of Regeneron...
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Modification No. 06 to Project Agreement, dated as of July 12, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 04 to Project Agreement, dated as of July 12, 2021, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 03 to Project Agreement, dated as of May 21, 2021, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 02 to Base Agreement, dated as of August 2, 2022, by and between Regeneron Pharmaceuticals, Inc. (the "Registrant") and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 0
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 5 to Project Agreement, dated as of March 22, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 1 to Base Agreement, dated as of January 26, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Second Amended and Restated Guaranty, dated as of March 2, 2022, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC,...
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Second Amended and Restated Participation Agreement, dated as of March 2, 2022, by and among Old Saw Mill Holdings LLC, as lessee, Bank of America, N.A., as administrative agent,...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
First Amendment to Amended and Restated Participation Agreement, dated as of October 6, 2021, by and among Old Saw Mill Holdings LLC, as lessee; the Registrant, as parent...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment No. 1 to Credit Agreement, dated as of November 11, 2021, by and among the Registrant, as a borrower and guarantor; certain direct subsidiaries of the Registrant, as...
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Modification No. 02 to Project Agreement, dated as of November 17, 2020, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Modification No. 01 to Project Agreement, dated as of October 13, 2020, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
First Supplemental Indenture, dated August 12, 2020, between the Company and U.S. Bank National Association
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Indenture, dated August 12, 2020, between the Company and U.S. Bank National Association
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Underwriting Agreement, dated August 7, 2020, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc., and J.P. Morgan Securities LLC, as representatives of the...
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Amendment No. 1 to Credit Agreement, dated as of June 11, 2020, by and between the Registrant, as borrower, and Goldman Sachs Bank USA, as administrative agent
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Credit Agreement, dated as of May 25, 2020, by and among Regeneron Pharmaceuticals, Inc., as borrower; Goldman Sachs Bank USA, as administrative agent, sole bookrunner, sole lead...
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Stock Repurchase Agreement, dated as of May 25, 2020, by and between Regeneron Pharmaceuticals, Inc. and Sanofi
Repurchase Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Underwriting Agreement, dated as of May 26, 2020, by and among Regeneron Pharmaceuticals, Inc., Sanofi, Aventisub LLC, and BofA Securities, Inc. and Goldman Sachs & Co. LLC, as...
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Stock Purchase Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
MA
2019
Amended and Restated Participation Agreement, dated as of May 2, 2019, by and among Old Saw Mill Holdings LLC, as lessee; Bank of America, N.A., as administrative agent; BA...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Amended and Restated Guaranty, dated as of May 2, 2019, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC, as...
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Form of stock option agreement and related notice of grant for use in connection with the grant of incentive stock options to P. Roy Vagelos, M.D. under the Amended and Restated...
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Form of stock option agreement and related notice of grant for use in connection with the grant of incentive stock options to the Registrant's executive officers under the Amended...
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Date:February 22, 2016To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River...
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Date:November 15, 2015To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River...
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Regeneron Pharmaceuticals, Inc.Notice of Grant of Stock OptionsID:[]and Option Agreement777 Old Saw Mill River RoadTarrytown, New York 10591[OPTIONEE NAME]OptionNumber:[][OPTIONEE...
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Date:August 5, 2015To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River...
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Amendment, dated as of May 14, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,...
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
REGENERON PHARMACEUTICALS, INC. Incentive Stock Option OPTION AGREEMENT PURSUANT TO THE REGENERON PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN CREDIT SUISSE INTERNATIONAL AND REGENERON PHARMACEUTICALS, INC.
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
REGENERON PHARMACEUTICALS, INC. 1.875% Convertible Senior Notes due 2016
Note Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
REGENERON PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2016 INDENTURE Dated as of October 21, 2011 WELLS FARGO BANK, NATIONAL ASSOCIATION Trustee
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
REGENERON PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2016 PURCHASE AGREEMENT
Note Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
5,500,000 SHARES REGENERON PHARMACEUTICALS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
EX-10.3: SUBSCRIPTION AGREEMENT
Subscription Agreements
Regeneron Pharmaceuticals
Biotechnology
2008